Stockscreener 앱 받기
3.22
0.63%
0.02
시간 외 거래:
3.28
0.06
+1.86%
Perspective Therapeutics Inc 주식(CATX)의 최신 뉴스
CATX Maintained by B of A Securities -- Price Target Lowered to $5.00 - GuruFocus
Bank of America Lowers Perspective Therapeutics (NYSEAMERICAN:CATX) Price Target to $5.00 - MarketBeat
Q3 EPS Forecast for Perspective Therapeutics Lifted by Analyst - MarketBeat
BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6 - marketscreener.com
Dimensional Fund Advisors LP Acquires 358,540 Shares of Perspective Therapeutics, Inc. $CATX - MarketBeat
Perspective Therapeutics (CATX) Stock Price, News & Analysis - marketbeat.com
Perspective Therapeutics (CATX): Millennium group reports over 5% beneficial stake - Stock Titan
Analysts Set Expectations for Perspective Therapeutics Q1 Earnings - MarketBeat
RBC Capital Sticks to Their Buy Rating for Perspective Therapeutics (CATX) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Atossa Therapeutics (ATOS), Corvus Pharmaceuticals (CRVS) and Perspective Therapeutics (CATX) - The Globe and Mail
Perspective Therapeutics, Inc. (CATX) Latest Stock News & Headlines - Yahoo Finance
Perspective Therapeutics (CATX) Gets a Buy from Oppenheimer - The Globe and Mail
Piper Sandler cuts Perspective Therapeutics price target on timing By Investing.com - Investing.com Australia
Perspective Therapeutics's NET Program Data May Allow Phase 3 Trial Start, Value Inflection, RBC Says - marketscreener.com
Piper Sandler cuts Perspective Therapeutics price target on timing - Investing.com
CATX Maintained by Piper Sandler -- Price Target Lowered to $14. - GuruFocus
Perspective Therapeutics (NYSEAMERICAN:CATX) Price Target Lowered to $14.00 at Piper Sandler - MarketBeat
Perspective Therapeutics Price Target Cut to $14.00/Share From $16.00 by Piper Sandler - Moomoo
Perspective Therapeutics earnings beat by $0.04, revenue fell short of estimates - Investing.com Canada
Perspective Therapeutics Reports Q2 Results and Pipeline Progress - TipRanks
Perspective Therapeutics Q2 FY26 net loss widens to $26.8 million - Bitget
Perspective Therapeutics (NYSEAMERICAN:CATX) Announces Quarterly Earnings Results - MarketBeat
Form 8K Perspective Therapeutics Inc For: 10 August By Investing.com - Investing.com Australia
Perspective Therapeutics Q2 EPS beats estimates as sales miss consensus - scanx.trade
Perspective Therapeutics: Q2 Earnings Snapshot - AOL.com
Perspective Therapeutics Reports $26.8 Million Q2 Net Loss - Quiver Quantitative
Perspective Therapeutics (CATX) expands cash to $236.9M while losses widen - Stock Titan
Perspective Therapeutics Q2 net loss widens on higher R&D costs - TradingView
Perspective Therapeutics (NYSE: CATX) grows cash to $237M while advancing Phase 3-ready pipeline - Stock Titan
Perspective Therapeutics Advances VMT-α-NET Toward Phase 3 as Pipeline and Manufacturing Expansion Progresses - Quiver Quantitative
Perspective Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Perspective Therapeutics Inc (CATX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MSN Money - MSN
Perspective Therapeutics Inc (CATX) Stock News Today - TradingKey
State Street Corporation (NYSE: CATX) reports 6.05M-share, 5.3% stake in Perspective - Stock Titan
Perspective Therapeutics (CATX) to Announce Earnings on Wednesday - MarketBeat
Are Medical Stocks Lagging Perspective Therapeutics, Inc. (CATX) This Year? - Yahoo Finance
Perspective Therapeutics (CATX) Gets a Buy from Wedbush - The Globe and Mail
Perspective Therapeutics updates corporate presentation, highlights progress across 212Pb radiopharmaceutical portfolio - TradingView
Perspective Therapeutics (NYSE: CATX) details 212Pb radiopharma pipeline - Stock Titan
Seven Fleet Capital Management LP Buys New Stake in Perspective Therapeutics, Inc. $CATX - MarketBeat
Perspective Therapeutics, Inc. $CATX Shares Bought by Avidity Partners Management LP - MarketBeat
Perspective Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 10 - Quiver Quantitative
Perspective Therapeutics (CATX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Yahoo! Finance Canada
BlackRock (CATX holder) discloses 6.8% beneficial stake in Perspective Therapeutics - Stock Titan
Perspective Therapeutics Inc (CATX) Balance Sheet - TradingKey
Perspective Therapeutics Receives European Orphan Medicinal Product Designation for [²¹²Pb]VMT-α-NET in GEP-NETs - quiverquant.com
Perspective Therapeutics wins EU orphan status for VMT-α-NET - scanx.trade
CATX|Perspective Therapeutics Inc|Price:2.820|Chg%:-0.090 - TradingKey
Perspective Therapeutics Inc (CATX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Perspective Therapeutics Inc (CATX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Perspective Therapeutics Inc (CATX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Perspective Therapeutics Inc (CATX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Perspective Therapeutics (CATX) Edges Lower as Stock Holds Above Key SupportRetail Driven Moves - dars.gov.et
Perspective Therapeutics Market Sentiment - Benzinga España
Perspective Therapeutics Inc (CATX) Cash Flow - TradingKey
Perspective Therapeutics Inc (CATX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Perspective Therapeutics Inc - TradingKey
Affinity Asset Advisors LLC Increases Stock Position in Perspective Therapeutics, Inc. $CATX - MarketBeat
Perspective Therapeutics Inc (CATX) Earnings Date & Reports & Earnings News - TradingKey
Perspective Therapeutics, Inc. Revenue Breakdown – TRADEGATE:AAJ0 - TradingView
BTIG reiterates Perspective Therapeutics stock rating on manufacturing edge - Investing.com
2.43%
자본화:
|
볼륨(24시간):